Lockshin Curtis 4
4 · Phio Pharmaceuticals Corp. · Filed Sep 15, 2025
Insider Transaction Report
Form 4
Lockshin Curtis
Director
Transactions
- Award
Common Stock, $.0001 par value
2025-09-11+16,200→ 18,555 total
Footnotes (3)
- [F1]Represents shares underlying a restricted stock unit, which shares will vest on the first annual anniversary of the grant.
- [F2]Includes shares of common stock underlying unvested restricted stock units.
- [F3]The number of reported securities has been adjusted to reflect prior reverse stock splits.